proliferation, and DNA ploidy were measured by DNA flow cytometry in a retrospective study of lymph node biopsy specimens from 83 cases (before treatment) of follicular non-Hodgkin's lymphoma, Working Formulation categories B and C. The correlations between these measures and survival, clinical stage, symptoms and histopathological factors were investigated. Aneuploidy was rare (n = 16) and had no effect on length of survival or transformation to high grade lymphoma. The overall mean S-phase fraction was 3-6%; for the whole series increasing S-phase fraction was associated with decreased survival. A high S-phase fraction (more than 5%) in initial biopsy specimens was also associated with an Outcome was assessed in terms of overall survival and relapse-free survival. The effects of histological pattern, cytological group, clinical stage, A and B symptoms, DNA ploidy and S-phase fraction on survival were analysed separately using life tables. Histological subtypes were compared for survival using the log rank test"3 and S-phase fractions in different groups were compared using the Wilcoxon rank sum test. To examine the independent effect of these factors on survival and to allow for varying lengths of follow up, Cox's proportional hazards model was applied. '4 Results Tables 1 and 2 show general characteristics for the whole series of 83 cases and the numbers of cases falling into various histological subtypes. The projected median survival for the whole series was 7x6 years. Complete remission was achieved in 51 % of cases and the median remission duration was 1x7 years. Forty four per cent ofthose achieving remission, however, subsequently relapsed. Because there was no consistent policy of taking biopsy specimens from patients to document relapse, histological material was available for only 22 of the patients who relapsed. At rebiopsy, 10 of these patients had transformed into high grade NHL while the remainder still showed low grade follicular NHL. In the main series there was no difference in survival between the cases falling into the various histological subtypes or clinical stages, although there was a trend for cases with mixed small and large cell histology to do slightly worse. Only eight cases showed clinically important sclerosis and there was no difference in either their survival or S-phase fraction compared with the main group. The survival of patients with B symptoms (median 21 months) was significantly (p = 0-02) worse than those with A symptoms. PLOIDY DNA aneuploidy was found in 16 of the 83 cases and the most common aneuploid DNA index was 1 1 (n = 7). There was no difference in survival between DNA diploid and aneuploid cases and there was no difference in the incidence of aneuploidy between various histological subtypes or clinical stages.
PROLIFERATIVE ACTIVITY
The mean S-phase fraction for the whole series of 83 patients was 3-6% with a median of 3 0% (table 2) . There was no difference between the S-phase fractions seen in various histological DNA Several studies have previously suggested that proliferative activity, measured by flow cytometry, Ki67 index, or mitotic index, affects the prognosis of follicular NHL. In these studies, however, the grouping of cases for analysis has often included a mixture of low grade lymphomas and results are not specific for follicular lymphomas.2"25 Alternatively, the effects of all the other factors such as symptoms, stage, histological subtype and architecture have not been studied or numbers are small.4 5 20 26 27 The major finding of our study is that proliferative activity seems to be the most important factor governing survival in follicular NHL, confirming previous more limited studies.4527 DNA aneuploidy was rare and had no prognostic effect. We also confirmed our previous finding that tumours with high proliferative activity in the initial biopsy specimen (more than 5%) were more likely to sustain high grade relapse.
Our results have implications for the treatment of follicular NHL. Although the decision to treat this disease must be based on consideration of factors such as symptoms, nevertheless the results presented here do provide an argument for treating follicular NHL with high proliferative activity with more aggressive therapeutic regimens.
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